Unilabs York Bioanalytical Solutions

Unilabs York Bioanalytical Solutions

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Unilabs York Bioanalytical Solutions is a UK-based, service-focused CRO with over 25 years of industry experience, specializing in bioanalysis, biomarkers, and metabolism studies for drug development. It leverages advanced analytical technologies like LC-MS/MS and immunoassays, supported by robust quality assurance systems and regulatory compliance (MHRA, FDA, DKMA). The company caters to a global clientele of pharma and biotech firms, providing critical data to accelerate therapeutic programs from early discovery to commercialization.

DiagnosticsBiologics

Technology Platform

Integrated bioanalytical platform utilizing LC-MS/MS, UPLC, and immunoassay instrumentation for small and large molecule analysis, supported by specialized LIMS (Watson, ClinAxys) and electronic notebook systems (Labnotes) for data management and high QA oversight.

Opportunities

Growing demand for outsourced bioanalytical services due to increasing R&D complexity and the rise of biologics and personalized medicine.
Its strong regulatory compliance record and niche expertise in challenging assays position it well to capture market share from both large pharma and virtual biotechs.

Risk Factors

High competition in the CRO sector, reliance on client R&D budgets which can be cyclical, and operational risks related to maintaining stringent regulatory compliance and retaining key scientific talent.
Any failure in quality systems could severely impact reputation.

Competitive Landscape

Operates in a crowded CRO market competing against large global players (e.g., LabCorp, IQVIA) and many specialized boutique labs. Differentiates through a strong focus on technical complexity (e.g., unstable metabolites, peptides), high QA standards, and a partnership-oriented approach to client service.